Post-marketing study of ropinirole prolonged release tablets in Parkinson’s disease: Evaluation outcomes associated with long term use of Ropinirole-PR using the clinical practice research datalink (CPRD) (111981)

23/02/2016
23/05/2024
EU PAS number:
EUPAS12518
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

gsk-111981-protocol-redact

English (1.57 MB - PDF) View document
Study results
Study results

gsk-111981-clinical-study-report-redact

English (3.74 MB - PDF) View document
Study report
Other information